Ocular Biodistribution Study for Topically Applied ESBA105

NCT00820014 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: Placebo

Sponsor

ESBATech AG